All Publications

Journals

• Tsang J; Chain BM; Miller RF; Webb BL; Barclay W; Towers GJ; Katz DR; Noursadeghi M. (13 Nov 2009). HIV-1 infection of macrophages is dependent on evasion of innate immune cellular activation. AIDS. 23:2255-2263. DOI.
• Scull MA; Gillim-Ross L; Santos C; Roberts KL; Bordonali E; Subbarao K; Barclay WS; Pickles RJ. (May 2009). Avian Influenza Virus Glycoproteins Restrict Virus Replication and Spread through Human Airway Epithelium at Temperatures of the Proximal Airways. PLOS PATHOG. 5. DOI.
• Wise HM; Foeglein A; Sun J; Dalton RM; Patel S; Howard W; Anderson EC; Barclay WS; et al. (Aug 2009). A complicated message: Identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J Virol. 83:8021-8031. DOI.
• Koudstaal W; Hartgroves L; Havenga M; Legastelois I; Ophorst C; Sieuwerts M; Zuijdgeest D; Vogels R; et al. (28 Apr 2009). Suitability of PER.C6 (R) cells to generate epidemic and pandemic influenza vaccine strains by reverse genetics. VACCINE. 27:2588-2593. DOI.
• Whiteley A; Major D; Legastelois I; Campitelli L; Donatelli I; Thompson CI; Zambon MC; Wood JM; et al. (Jul 2007). Generation of candidate human influenza vaccine strains in cell culture - rehearsing the European response to an H7N1 pandemic threat. Influenza Other Respi Viruses. 1:157-166. DOI.
• Cox RJ; Madhun AS; Hauge S; Sjursen H; Major D; Kuhne M; Höschler K; Saville M; et al. (18 Mar 2009). A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine. Vaccine. 27:1889-1897. DOI.
• Barclay W. (11 Oct 2008). Bird flu is out there just biding its time (vol 199, pg 8, 2008). NEW SCI. 200:21-21.
• Hale BG; Barclay WS; Randall RE; Russell RJ. (15 Aug 2008). Structure of an avian influenza A virus NS1 protein effector domain. VIROLOGY. 378:1-5. DOI.
• Owen RE; Yamada E; Thompson CI; Phillipson LJ; Thompson C; Taylor E; Zambon M; Osborn HMI; et al. (Oct 2007). Alterations in receptor binding properties of recent human influenza H3N2 viruses are associated with reduced natural killer cell lysis of infected cells. J VIROL. 81:11170-11178. DOI.
• Barclay WS; Jones IM; Osborn HMI; Phillipson L; Ren JY; Talevera GA; Thompson CI. (15 Jun 2007). Probing the receptor interactions ofan H5 avian influenza virus using a baculovirus expression system and functionalised poly(acrylic acid) ligands. BIOORGAN MED CHEM. 15:4038-4047. DOI.
• Zambon M; Barclay W. (7 Dec 2002). Unravelling the mysteries of influenza. Lancet. 360:1801-1802. DOI.
• Powell R; Ren J; Lewith G; Barclay W; Holgate S; Almond J. (Oct 2003). Identification of novel expressed sequences, up-regulated in the leucocytes of chronic fatigue syndrome patients. Clin Exp Allergy. 33:1450-1456.
• Jackson D; Zürcher T; Barclay W. (1 May 2004). Reduced incorporation of the influenza B virus BM2 protein in virus particles decreases infectivity. Virology. 322:276-285. DOI.
• Jackson D; Barclay W; Zürcher T. (Feb 2005). Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations. J Antimicrob Chemother. 55:162-169. DOI.
• Hayman A; Comely S; Lackenby A; Murphy S; McCauley J; Goodbourn S; Barclay W. (30 Mar 2006). Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway. Virology. 347:52-64. DOI.
• Howard W; Hayman A; Lackenby A; Whiteley A; Londt B; Banks J; McCauley J; Barclay W. (Mar 2007). Development of a reverse genetics system enabling the rescue of recombinant avian influenza virus A/Turkey/England/50-92/91 (H5N1). Avian Dis. 51:393-395.
• Barclay WS; Zambon M. (31 Jan 2004). Pandemic risks from bird flu - The risk to humans is small, but we need to be better prepared. BRIT MED J. 328:238-239.
• Yao Y; Mingay LJ; McCauley JW; Barclay WS. (Jun 2001). Sequences in influenza A virus PB2 protein that determine productive infection for an avian influenza virus in mouse and human cell lines. J Virol. 75:5410-5415. DOI.
• Jackson D; Cadman A; Zurcher T; Barclay WS. (Nov 2002). A reverse genetics approach for recovery of recombinant influenza B viruses entirely from cDNA. J Virol. 76:11744-11747.
• Harvey R; Martin AC; Zambon M; Barclay WS. (Jan 2004). Restrictions to the adaptation of influenza a virus h5 hemagglutinin to the human host. J Virol. 78:502-507.
• Barclay WS; Zambon M. (31 Jan 2004). Pandemic risks from bird flu. BMJ. 328:238-239. DOI.
• Griffin SD; Harvey R; Clarke DS; Barclay WS; Harris M; Rowlands DJ. (Feb 2004). A conserved basic loop in hepatitis C virus p7 protein is required for amantadine-sensitive ion channel activity in mammalian cells but is dispensable for localization to mitochondria. J Gen Virol. 85:451-461.
• Thompson CI; Barclay WS; Zambon MC. (May 2004). Changes in in vitro susceptibility of influenza A H3N2 viruses to a neuraminidase inhibitor drug during evolution in the human host. J Antimicrob Chemother. 53:759-765. DOI.
• Elleman CJ; Barclay WS. (30 Mar 2004). The M1 matrix protein controls the filamentous phenotype of influenza A virus. Virology. 321:144-153. DOI.
• Heydarnejad J; Barclay WS; Izadpanah K; Hunter FR; Gooding MJ. (Feb 2006). Molecular characterization of Iranian wheat stripe virus shows its taxonomic position as a distinct species in the genus Tenuivirus. Arch Virol. 151:217-227. DOI.
• Thompson CI; Barclay WS; Zambon MC; Pickles RJ. (Aug 2006). Infection of human airway epithelium by human and avian strains of influenza a virus. J Virol. 80:8060-8068. DOI.
• Hayman A; Comely S; Lackenby A; Hartgroves LC; Goodbourn S; McCauley JW; Barclay WS. (Mar 2007). NS1 proteins of avian influenza A viruses can act as antagonists of the human alpha/beta interferon response. J Virol. 81:2318-2327. DOI.

Conferences

• Whiteley A; Trikic MZ; Barclay WS. Attenuating mutations in the influenza virus genome which may increase the safety of vaccine production. 5th International Conference on Options for the Control of Influenza, 7 Oct 2003 - 11 Oct 2003. 1263:687-690. ELSEVIER SCIENCE BV (2004). DOI.